Scientists have discovered a novel molecular pathway for an enzyme inhibitor in humans that plays a direct role in the development of high cholesterol and nonalcoholic fatty liver disease, which they then were able to reverse ...
Mar 25, 2019
0
7
(HealthDay)—Two drugs have been approved by the U.S. Food and Drug Administration for the treatment of rare blood diseases, the agency announced Friday.
Dec 24, 2018
0
211
An immunotherapy drug will be made available to some patients with advanced melanoma skin cancer on the NHS in England.
Nov 30, 2018
0
1
"Civilization begins with distillation," said William Faulkner, a writer and drinker. Although our thirst for alcohol dates back to the Stone Age, nobody has figured out a good way to deal with the ensuing hangover after ...
May 9, 2018
0
2
A new study published today in the Journal of Pediatrics is the first to show that weight gain may have a negative impact on liver health in children as young as 8 years old. The study found that bigger waist circumference ...
Apr 4, 2018
0
30
(HealthDay)—In a report published online July 16 in the Journal of Clinical Pharmacy and Therapeutics, a case of survival after acute liver failure secondary to amiodarone administration is described.
Jul 19, 2017
0
0
Liver cirrhosis is the 12th leading cause of mortality worldwide and approximately half of those deaths are due to alcohol abuse. Yet apart from alcohol abstinence, there are no specific treatments to reduce the severity ...
May 22, 2017
0
48
Taking tissue samples from the liver to diagnose fatty liver can be replaced in most cases by a painless magnetic resonance investigation. This is the conclusion of a new study from Linköping University in Sweden, published ...
Apr 6, 2017
0
1
It can start with the quick check of a box. A doctor orders a range of blood tests all at once, hoping to figure out what's causing a patient to show signs of liver damage. It sounds harmless enough - and faster and more ...
Mar 2, 2017
0
75
Researchers at Duke Health have identified a potential new avenue for treating Pompe disease, a rare condition caused by the build-up of glycogen, a storage form of sugar, in cardiac and skeletal muscle, the liver and other ...
Jul 27, 2016
0
6
